Yield Theory

Stock research

Healthpeak Properties, Inc. DOC

Healthpeak Properties owns healthcare real estate including lab, medical-office, and senior-housing space.
Loading delayed market data…

Delayed Cboe One market data via TradingView. It may differ from primary-exchange or consolidated quotes.

Ticker
DOC
Exchange
NYSE
Sector
Real
Founded

What moves DOC

Healthpeak Properties, Inc. sits in Real Estate. REITs across offices, data centers, industrial, and residential — the most rate-sensitive corner of the equity market. The forces that matter most for the sector — and therefore for DOC — are:

  • Long-term interest rates and cap rates
  • Occupancy and rent growth by property type
  • Data-center demand from AI workloads
  • Refinancing walls and commercial credit

Congressional trading in DOC

No matched DOC transaction appears in the current verified House Clerk snapshot. We do not turn a missing row into a claim that no member has ever traded the security.

Congressional disclosures are delayed, range-based records—not real-time signals or proof of motive. See the source-linked tracker for scope and limitations.

The profile is free

DOC research stays free. Membership is the living thesis: what we believe, what we’re watching, and when conviction should end.

Get this month’s call for $15

How Yield Theory covers DOC

DOC intersects several of the themes in every Yield Theory issue. We don't chase headlines on individual tickers — we track where capital is rotating and explain what it means for the names in its path.

US marketsRates & central banks

DOC — frequently asked questions

What sector is DOC in?

Healthpeak Properties, Inc. is classified in the Real Estate sector and trades on the NYSE.

Do members of Congress trade DOC?

The current verified House Clerk snapshot contains no matched DOC transaction rows. That is not proof that no lawmaker has ever traded the security.

Is DOC a good investment?

We don't publish one-line buy/sell ratings. Yield Theory members get the full macro thesis, catalysts, and risks behind every name we cover, so you can decide with conviction. This page is research, not investment advice.

This page is independent research and educational information, not investment advice or a recommendation to buy or sell any security. Company facts are compiled from public sources. Do your own research.

See whether the DOC thesis still holds.

This page is company context and filings. Members get one sourced monthly call, a weekly evidence check, and the breakpoint written in advance. $15/month or $150/year.

$15/mo or $150/yr · cancel future renewals anytime · sources included